Article Details

Roche multiple sclerosis subcutaneous injection: late-breaking data

Retrieved on: 2023-10-11 16:23:45

Tags for this article:

Click the tags to see associated articles and topics

Roche multiple sclerosis subcutaneous injection: late-breaking data. View article details on HISWAI: https://www.europeanpharmaceuticalreview.com/news/187544/roche-multiple-sclerosis-subcutaneous-injection-late-breaking-data/

Excerpt

Data for Roche's RMS/PPMS subcutaneous injection. The new late-breaking data from the Phase III OCARINA II study showed that OCREVUS subcutaneous ...

Article found on: www.europeanpharmaceuticalreview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up